Literature DB >> 23143628

Etiology and survival of aplastic anemia: a study based on clinical investigation.

Dharmendra Jain1, Ritesh Kumar, Neetu Tyagi, Avinash Negi, Amit Pande, Amita Mahajan, Prashant K Pandey, Radhika Malik, Vimarsh Raina, Balwant K Malik.   

Abstract

BACKGROUND: Management of aplastic anemia is etiology driven, whether constitutional or acquired. Age, gender, and severity of disease also play crucial role in the survival of aplastic anemia. Since, inadequate data are available from India, the present study was conducted with the aim to evaluate the etiology and survival of aplastic anemia.
METHODS: Three hundred patients were enrolled between May 2007 and April 2010. Severity analysis and chromosomal breakage study was performed and patients were followed up to calculate the survival rate.
RESULTS: Only 9.4% of the cases demonstrated the evidence of constitutional disease. Patients with acquired disease showed a significantly higher odd ratio for hepatitis. Overall survival was found to be independent of the gender and inherited etiology. Phenotype resembling to constitutional disease was present in only 22.22% (6/27) of patients. Similar ratio of the constitutional and acquired disease in both the age groups was observed.
CONCLUSION: Irrespective of the age and phenotype, chromosomal breakage study should be mandatory for all patients with aplastic anemia. Hepatitis as a preceding event may be associated with the cause of aplastic anemia. Young age and less severe disease were strongly associated with better survival. Lack of tertiary care facility in the country, time lag between diagnosis and treatment, and unaffordability to abide the treatment cost could be the major contributory factors for poorer survival.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23143628      PMCID: PMC6807622          DOI: 10.1002/jcla.21546

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  27 in total

1.  Aplastic anemia: which treatment?.

Authors:  J L Abkowitz
Journal:  Ann Intern Med       Date:  2001-10-02       Impact factor: 25.391

2.  Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.

Authors:  Richard E Champlin; Waleska S Perez; Jakob R Passweg; John P Klein; Bruce M Camitta; Eliane Gluckman; Christopher N Bredeson; Mary Eapen; Mary M Horowitz
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

3.  Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology.

Authors:  Daniel Levy; Susan L Neuhausen; Steven C Hunt; Masayuki Kimura; Shih-Jen Hwang; Wei Chen; Joshua C Bis; Annette L Fitzpatrick; Erin Smith; Andrew D Johnson; Jeffrey P Gardner; Sathanur R Srinivasan; Nicholas Schork; Jerome I Rotter; Utz Herbig; Bruce M Psaty; Malinee Sastrasinh; Sarah S Murray; Ramachandran S Vasan; Michael A Province; Nicole L Glazer; Xiaobin Lu; Xiaojian Cao; Richard Kronmal; Massimo Mangino; Nicole Soranzo; Tim D Spector; Gerald S Berenson; Abraham Aviv
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

4.  Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors.

Authors:  Vikas Gupta; Mary Eapen; Ruta Brazauskas; Jeanette Carreras; Mahmoud Aljurf; Robert Peter Gale; Gregory A Hale; Osman Ilhan; Jakob R Passweg; Ollé Ringdén; Mitchell Sabloff; Hubert Schrezenmeier; Gerard Socié; Judith C W Marsh
Journal:  Haematologica       Date:  2010-09-17       Impact factor: 9.941

5.  Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia.

Authors:  J Y Mary; E Baumelou; M Guiguet
Journal:  Blood       Date:  1990-04-15       Impact factor: 22.113

6.  Severe aplastic anaemia in the Nordic countries: a population based study of incidence, presentation, course, and outcome.

Authors:  N Clausen; A Kreuger; T Salmi; I Storm-Mathisen; G Johannesson
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

7.  Aplastic anaemia: an analysis of 174 patients.

Authors:  M A Mir; C G Geary
Journal:  Postgrad Med J       Date:  1980-05       Impact factor: 2.401

8.  Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors.

Authors:  Amelia Găman; G Găman; Adriana Bold
Journal:  Rom J Morphol Embryol       Date:  2009       Impact factor: 1.033

Review 9.  Hematopoietic stem cells.

Authors:  Michael E Trigg
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

10.  Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia.

Authors:  Yuko Osugi; Hiroshi Yagasaki; Masahiro Sako; Yoshiyuki Kosaka; Takashi Taga; Tsuyoshi Ito; Masuji Yamamoto; Akira Ohara; Takeyuki Sato; Junichi Mimaya; Ichiro Tsukimoto; Seiji Kojima
Journal:  Haematologica       Date:  2007-12       Impact factor: 9.941

View more
  1 in total

1.  Metabolomics-Based Clinical Efficacy of Compound Shenlu Granule, a Chinese Patent Medicine, in the Supportive Management of Aplastic Anemia Patients: A Randomized Controlled Pilot Trial.

Authors:  Zhou Feng; Xiaoying Hu; Weiying Qu; Xiaoqin Zhu; Jiaying Lu; Zhongdi Huang; Lin Zhao; Pei Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-30       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.